Progression to overt or silent cad in asymptomatic patients with diabetes mellitus at high coronary risk: Main findings of the prospective multicenter bardot trial with a pilot randomized treatment substudy

JACC: Cardiovascular Imaging

Volumn 7, Issue 10, 2014, Pages 1001-1010

  Zellweger, Michael J ^a   Maraun, Michael ^b   Osterhues, Hans H ^c   Keller, Ulrich ^a   Müller Brand, Jan ^a   Jeger, Raban ^a   Pfister, Otmar ^a   Burkard, Thilo ^a   Eckstein, Friedrich ^a   Von Felten, Stefanie ^a   Osswald, Stefan ^a   Pfisterer, Matthias ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b District Hospital   (Germany)

^c District Hospital   (Germany)

Author keywords

coronary artery disease; diabetes type 2; myocardial perfusion SPECT; risk stratification; silent ischemia; treatment

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SILENT MYOCARDIAL INFARCTION; SILENT MYOCARDIAL ISCHEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME; ASYMPTOMATIC DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; MYOCARDIAL PERFUSION IMAGING; PROCEDURES; RISK ASSESSMENT; SCINTISCANNING;

ASYMPTOMATIC DISEASES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; HUMANS; MYOCARDIAL PERFUSION IMAGING; PILOT PROJECTS; PREVALENCE; RISK ASSESSMENT; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84908025702     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2014.07.010     Document Type: Article

References (29)

1. M.M. Lievre, P. Moulin, C. Thivolet DYNAMIT investigators Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening Trials 12 2011 23
2. F.J. Wackers, L.H. Young, S.E. Inzucchi Detection of Ischemia in Asymptomatic Diabetics Investigators Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study Diabetes Care 27 2004 1954 1961
3. L.H. Young, F.J. Wackers, D.A. Chyun DIAD Investigators Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial JAMA 301 2009 1547 1555
4. S. Bansal, F.J. Wackers, S.E. Inzucchi DIAD Study Investigators Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis Diabetes Care 34 2011 204 209
5. F.J. Wackers, and L.H. Young Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study J Nucl Cardiol 16 2009 855 859
6. American Diabetes Association Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida Diabetes Care 21 1998 1551 1559
7. American Diabetes Association Standards of medical care in diabetes - 2014 Diabetes Care 37 Suppl 1 2014 S14 S80
8. L. Rydén, P.J. Grant, and S.D. Anker ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) Eur Heart J 34 2013 3035 3087
9. D.J. Ewing, C.N. Martyn, R.J. Young, and B.F. Clarke The value of cardiovascular autonomic function tests: 10 years experience in diabetes Diabetes Care 8 1985 491 498
10. N.F. Ehl, M. Kühne, M. Brinkert, J. Müller-Brand, and M.J. Zellweger Diabetes reduces left ventricular ejection fraction - irrespective of presence and extent of coronary artery disease Eur J Endocrinol 165 2011 945 951
11. F.J. Klocke, M.G. Baird, B.H. Lorell American College of Cardiology, American Heart Association, American Society for Nuclear Cardiology ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) J Am Coll Cardiol 42 2003 1318 1333
12. M.J. Zellweger, C. Kaiser, and R. Jeger Coronary artery disease progression late after successful stent implantation J Am Coll Cardiol 59 2012 793 799
13. D.S. Berman, A. Abidov, and X. Kang Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation J Nucl Cardiol 11 2004 414 423
14. K. Thygesen, J.S. Alpert, A.S. Jaffe Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction Third universal definition of myocardial infarction Circulation 126 2012 2020 2035
15. M.J. Zellweger, E.A. Dubois, and S. Lai Risk stratification in patients with remote prior myocardial infarction using rest-stress myocardial perfusion SPECT: prognostic value and impact on referral to early catheterization J Nucl Cardiol 9 2002 23 32
16. N. Arenja, C. Mueller, and N.F. Ehl Prevalence, extent, and independent predictors of silent myocardial infarction Am J Med 126 2013 515 522
17. R.F. Davies, A.D. Goldberg, and S. Forman Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization Circulation 95 1997 2037 2043
18. P. Erne, A.W. Schoenenberger, and M. Zuber Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study Eur Heart J 28 2007 2110 2117
19. TIME Investigators Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial Lancet 358 2001 951 957
20. M.J. Zellweger, and M.E. Pfisterer Silent coronary artery disease in patients with diabetes mellitus Swiss Med Wkly 131 2001 427 432
21. M.K. Rutter, S.T. Wahid, J.M. McComb, and S.M. Marshall Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes J Am Coll Cardiol 40 2002 56 61
22. L. Zhang, H. Li, S. Zhang, L.M. Jaacks, Y. Li, and L. Ji Silent myocardial ischemia detected by single photon emission computed tomography (SPECT) and risk of cardiac events among asymptomatic patients with type 2 diabetes: a meta-analysis of prospective studies J Diabetes Complications 28 2014 413 418
23. R. Hachamovitch, S. Hayes, and J.D. Friedman Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol 41 2003 1329 1340
24. N. Aldweib, K. Negishi, R. Hachamovitch, W.A. Jaber, S. Seicean, and T.H. Marwick Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization J Am Coll Cardiol 61 2013 1616 1623
25. D.J. Maron, and J.S. Hochman Revascularization for silent ischemia?: another piece of the puzzle J Am Coll Cardiol 61 2013 1624 1625
26. P. Sorajja, P. Chareonthaitawee, and N. Rajagopalan Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting Circulation 112 9 Suppl 2005 I311 I316
27. L.J. Shaw, D.S. Berman, D.J. Maron COURAGE Investigators Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
28. L.J. Shaw, M.D. Cerqueira, and M.M. Brooks Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial J Nucl Cardiol 19 2012 658 669
29. BARI 2D Study Group R.L. Frye, P. August, and M.M. Brooks A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515